SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-189232
Filing Date
2019-07-03
Accepted
2019-07-03 16:12:06
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d758816ds3.htm S-3 446620
2 EX-1.2 d758816dex12.htm EX-1.2 198897
3 EX-4.4 d758816dex44.htm EX-4.4 352376
4 EX-4.5 d758816dex45.htm EX-4.5 347546
5 EX-4.6 d758816dex46.htm EX-4.6 45363
6 EX-4.7 d758816dex47.htm EX-4.7 46527
7 EX-5.1 d758816dex51.htm EX-5.1 30432
8 EX-23.1 d758816dex231.htm EX-23.1 1623
9 GRAPHIC g758816g33j00.jpg GRAPHIC 39196
10 GRAPHIC g758816g34r31.gif GRAPHIC 2645
11 GRAPHIC g758816g47n40.gif GRAPHIC 8319
  Complete submission text file 0001193125-19-189232.txt   1539847
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-232543 | Film No.: 19942019
SIC: 2836 Biological Products, (No Diagnostic Substances)